Atlas Trials

Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.

Clinical trial NCT06159920 · UNKNOWN

Trial details

NCT number
NCT06159920
Sponsor
IRCCS San Raffaele
Status
UNKNOWN
Study type
OBSERVATIONAL
Neuroendocrine Tumors
Start date
2021-10-27
Primary completion
2024-12-27
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.